Cliff Asness's MAZE Position Overview
Cliff Asness (via Aqr Capital Management LLC) currently holds 27,439 shares of Maze Therapeutics, Inc. (MAZE) worth $1.14 M, representing 0.00% of the portfolio. First purchased in 2025-Q2, this short-term holding has been held for 3 quarters.
Based on 13F filings, Cliff Asness has maintained this position in MAZE for several quarters, showing initial confidence in the investment. Largest addition occurred in Q3 2025, adding 148 shares. Largest reduction occurred in Q4 2025, reducing 176 shares.
Analysis based on 13F filings available since 2013 Q2
Cliff Asness's Maze Therapeutics (MAZE) Holding Value Over Time
Track share changes against reported price movement
Quarterly Maze Therapeutics (MAZE) Trades by Cliff Asness
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -176 | Reduce 0.64% | 27,439 | $41.43 |
| Q3 2025 | +148 | Add 0.54% | 27,615 | $25.93 |
| Q2 2025 | +27,467 | New Buy | 27,467 | $12.27 |
Cliff Asness's Maze Therapeutics Investment FAQs
Cliff Asness first purchased Maze Therapeutics, Inc. (MAZE) in Q2 2025, acquiring 27,467 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Cliff Asness has held Maze Therapeutics, Inc. (MAZE) for 3 quarters since Q2 2025.
Cliff Asness's largest addition to Maze Therapeutics, Inc. (MAZE) was in Q2 2025, adding 27,467 shares worth $337,020.
According to the latest 13F filing for Q4 2025, Cliff Asness's firm, Aqr Capital Management LLC, owns 27,439 shares of Maze Therapeutics, Inc. (MAZE), valued at approximately $1.14 M.
As of the Q4 2025 filing, Maze Therapeutics, Inc. (MAZE) represents approximately 0.00% of Cliff Asness's publicly disclosed stock portfolio, making it one of their key holdings.
Cliff Asness's peak holding in Maze Therapeutics, Inc. (MAZE) was 27,615 shares, as reported at the end of Q3 2025.